Blood viscosity and viscometers
Haemorheology is concerned with the study of the factors inherent in blood which can limit its ability to flow. Of these factors the viscosity of blood and of plasma are crucial and much of the literature in this area is concerned with their measurement, the parameters which affect them, their role in the development of disease and their use as diagnostic indices. The meeting of the Forum on Clinical Haemorheology held at Southampton General Hospital on 12 April 1985, which was devoted primarily to blood and plasma viscosity and their measurement, was therefore of particular interest to the members of the Forum.
The meeting opened with a review of some recent trends in viscometry given by Dr Arpad Matrai (University of Munich). He started with a discussion of instruments designed primarily for the measurement of the viscosity of blood plasma. Such instruments are of growing interest to haematologists since the viscosity of plasma provides a sensitive index of disturbances of plasma protein concentration. Consequently, plasma viscosity is increasingly replacing the erythrocyte sedimentation rate (ESR) as a nonspecific index of pathology. It has the further advantages of being a quicker index to measure, has more specific interpretation and leads to fewer false-positive or negative results'. The original instrument in this field was the Coulter-Harkness capillary viscometer (Coulter Electronics, Luton, UK) in which the application of Poiseuille's equation to the flow of plasma through a capillary permits the plasma viscosity to be determined. However, Dr Matrai also described two new instruments, the Rheomed plasma viscometer (Homburg, West Germany) based on a similar design, and that by Haake (Karlsruhe, West Germany) which is based on the measurement of the rate of fall of a ball through the sample under test, from which the viscosity is determined by the application of Stoke's Law. The prime raison d'etre of these newer instruments is to simplify their use, thus making them more relevant to the environment of a busy routine laboratory, and to reduce the amount of sample needed. These aims had been achieved but at some financial cost, as shown in Table 1 which summarizes Dr Matrai's findings.
The presentation then moved to the measurement of whole blood viscosity. This measurement is substantially more complex than that of plasma alone because of the biphasic nature of blood, and is further complicated by the facts that the cells are deformable, tend to aggregate and to settle out with time. However, several adequate rotational viscometers are available for making these measure-ments2. Using such instruments it is easy to show that the cellular components endow blood with nonnewtonian viscosity characteristics, in particular the increase in viscosity as shear rate falls. At high shear rates the technical problems of measurement are not great and the various instruments agree well3; but at low shear rate, where the effects of aggregation can be very substantial, much care is needed to overcome artifacts and it is vital that precise details of measurement techniques are included with any data reported in this area.
Finally Dr Matrai covered a development of increasing interest, that is the use of viscometers that impose oscillatory stress patterns on the samples under test. These allow the phase:amplitude relationships of the stress and resultant strain to be obtained. Under these conditions blood exhibits viscoelastic characteristics and these instruments allow the viscous and elastic components to be separated4. This gives information on cellular aggregation and the response of blood to pulsatile pressure patterns, the latter being a relatively unstudied area but obviously one of relevance in vivo.
Yet another plasma viscometer was the subject of the next talk, by Dr AC Fisher (University of Strathclyde). He compared the performance of that manufactured by Luckham (Burgess Hill, UK) with the Coulter-Harkness instrument. The new machine is also based on a capillary flow system. He found that the instruments were of comparable accuracy though the Luckham instrument was easier to use, cheaper and did not require a water bath for making measurements at 37°C. However, both were prone to errors if calibrated only with water because of its lower viscosity compared to plasma, and because of the effect of inertial and end-effect contributions. He recommended that if single-point calibration be made, it be done using a sucrose standard solution with viscosity in the middle of the working range for plasma.
It is rare at a small meeting of this kind that a unique approach to tackling a problem is presented, but one such was provided by Mr J A Evans (University College of North Wales). Current viscometers used in haemorheology are all based on measuring the stress:flow relationships of samples or the rate of fall of a ball through the liquid being investigated. The Bangor group, however, were studying the use of piezoelectric materials to measure viscosity. Ultrasonic waves can easily be established on the surface of such materials, but if a thin film of liquid is placed on its surface then damping of the signal occurs. Mr Evans reported that using as little as 25 pl of simple liquids, such as glycerol solutions, the wave attenuation was linearly related to viscosity. Thus these devices clearly have potential as viscometers, and the great advantage of requiring only very small samples. Currenti studies using plasma have shown that some samples gave results that-agreed well with those from a Coulter-Harkness instrument, while others did not. The reasons for this were being studied. Another potential use of these devices was as coagulometers as their responses varied very rapidly if a thin film of blood was allowed to clot on the surface.
The final paper concerned primarily with plasma viscosity was delivered by Dr G D 0 Lowe (Glasgow Royal Infirmary). He reported on a study that his group had made of the relationship of plasma and serum viscosities to the presence of angina pectoris, to the activation of coagulation and fibrinolysis as assessed by radioimmunoassays of fibrinopeptide-A (thrombin activity) and fibrin fragment B /1 15-42 (plasma activity), and to vascular risk factors (age, smoking,;blood pressure, overweight, serum cholesterol, and serum triglyceride). Of 500 men aged 35-55 years included in the study, 105 gave a positive response in the Rose, questionnaire for angina pectoris during a health screening study, the other 395 were matched controls without angina.
Preliminary analysis of the results showed that patients and controls had similar levels of plasma and serum viscosity, fibrinopeptide A and fragment Bf-t 15-42. Significant correlations were observed between plasma viscosity and increasing levels of fibrinopeptide A, and between plasma viscosity and decreasing level of fragment B ft 15-42. Thus even in healthy subjects, elevated plasma viscosity was associated with increased coagulation and decreased fibrinolysis. Since serum viscosity showed similar correlations, these associations do not appear to reflect mutual correlation with plasma fibrinogen. Three interpretations are possible. Firstly, increased plasma viscosity might promote activation of coagulation and decreased fibrinolysis (e.g.by shearingeffects on blood vessel walls). Secondly, disturbances of coagulation or fibrinolysis might increase plasma viscosity (e.g. fibrin degradation products may stimulate hepatic synthesis of acute phase proteins). Thirdly, the correlations might arise from mutual associations with other factors such as vascular risk factors. For example, increasing concentrations of cholesterol and triglyceride were associated with increased plasma and serum viscosity, increasing fibrinopeptide A levels, and decreasing fragment B ft 15-42 levels.
There followed a number of papers not directly concerned with viscosity measurement, but rather with factors which can affect viscosity. Dr Denise Syndercombe Court (The London Hospital Medical College) explained that the Coulter principle for estimating cell volume is based on the measurement of the change in electrical impedance that takes place as a cell passes through a small fluid-filled orifice. She argued that the response will depend, however, not only on volume but also on the orien-tation and shape of the cell as it passes through the measuring region. Hence, since cells passing through this region will be deformed by the varying shear stresses, the response of the instruments could offer a means of obtaining an index of deformability. To test the idea the mean cell volumes (MCV) of erythrocytes obtained from a Coulter S with 100 um orifice and a Coulter S Plus with a 50 pm orifice (Coulter Electronics, Luton, UK) were compared. It was found that the ratio of the two readings varied from sample to sample, in particular cells with low mean cellular haemoglobin concentration (MCHC) appeared to be smaller when the Coulter S Plus was used. She suggested that this implies greater flexibility in these cells compared with normals.
The next paper by Dr F E Cotter (The London
Hospital) reported on a rheological study of 170 polycythaemics. These were put into an irondeficiency group (MCV 0.76 g/dl, ferritin 8 ng/1) or into a second group with higher parameters. It was found that whole blood viscosity, at 23 or 230 s -', was significantly higher in the iron-deficient group and that this related to the higher red cell count. No relationship was found between viscosity and red cell deformability or fibrinogen concentration. A significant negative correlation was also found between platelet count and viscosity, though this was probably indirectly related to the increased red cell production'.
In a related paper Mr D W Lane (Scarborough General Hospital) said that as the MCHC decreases in hypochromic patients, so the blood haemoglobin concentration (Hb) falls relative to the packed cell volume (PCV). Hence patients with microcytic polycythaemia who are controlled by PCV measurement tend to have a lower Hb. As an example, one such patient suffering from hyperviscosity with Hb 17.5 g/dl, MCV 66 fl and high shear rate blood viscosity of 6.99mPas was treated with iron (FeSO4 200mg twice daily) and weekly venesections for one month. The effectiveness of the treatment was shown by the fact that even after 3 months, with no intervening therapy, Hb was back to 17.4 g/dl and the MCV had risen to 78 fl. The rheologically important point, however, was that the blood viscosity had fallen to 5.36 mPas. The patient was also clinically asymptomatic. Mr Lane considered, therefore, that there are good reasons for believing that such therapy could be of general benefit to microcytic polycythaemics.
A major factor responsible for the rapid increase of blood viscosity as the shear rate falls is rouleaux formation. Currently this is of considerable interest in its own right and various methods are available for making estimates of it. In his paper Dr M W Rampling (St Mary's Hospital Medical School) compared four of the more common techniques: the use of the Microscope Aggregation Index (MAI)6, low shear rate (0.28 s-1) viscosity (LSRV)7, the erythrocyte sedimentation rate (ESR) with appropriate observation time7 and the, Myrenne Erythrocyte Aggregometer (MEA) (Roetgen, West Germany). Of these, only the MAI gives an unequivocal index of aggregation since it is based on microscopic observation of the cells, and its use showed that in a washed system between 50 and 100 mg/100 ml of fibrinogen was necessary before erythrocyte aggregation began. The response thresholds for the LSRV and ESR were similar, but the MEA failed to respond until the fibrinogen level reached some 250 mg/ 100 ml. Nevertheless, once aggregation became substantial, the MEA was particularly sensitive to the concentration of aggregating agent. Because of this, its speed and simplicity of use, and the small volume of sample needed, it is especially attractive for clinical studies related to rouleaux formation.
The final session consisted of an open discussion between the Forum members and representatives of the companies exhibiting rheological equipment at the meeting. The broad-ranging and frank nature of the comments made were of benefit to both sides and a fitting way to round off a meeting primarily concerned with technology. of great interest to members of the Society. First and foremost I can report that Her Majesty The Queen and His Royal Highness The Duke of Edinburgh have graciously consented to honour us with their presence on the afternoon of Wednesday 2 July, when The Queen will formally open the entire refurbished RSM premises and so complete a venture which has been 30 years in the making in practical terms but which has been nurtured by members of the Society over a much longer period. It will herald the closing of a chapter in the Society's history and the opening of a new one which we all hope will bring the RSM even greater renown than it enjoys at present and will extend its activities both nationally and internationally.
M W Rampling
By the time the opening ceremony is performed the staff of the Society will have been occupying their refurbished office accommodation for some two or three months and the Barnes Hall and West Hall will be in full use for meetings, conferences and other events. The library, too, will once more be fully operational and available to the membership, and the complete range of its services will again be operating in more congenial surroundings. It was in May 1962 that Her Majesty last attended an occasion at 1 Wimpole Street, when a soiree was held to commemorate the fiftieth anniversary of the opening of the Society's house by Their Majesties King George V and Queen Mary on 21 May 1912. In the foreword to the brochure produced on the occasion of that visit the then President, the Rt Hon Lord Adrian OM MD FRS, wrote: 'Fifty years ago, the Royal Society of Medicine moved to its spacious new building at 1 Wimpole Street and was honoured by Their Majesties King George V and Queen Mary who came to perform the opening ceremony. In its new home the Society could be satisfied that there would be space for its great library and for the meetings of the Sections in every branch of medicine. Fifty years later the building has been enlarged, the library is overflowing and the advance of medical science has given new impetus to our activities which we must not neglect but we can be proud of the work which the Society has carried out here for half a century and in the knowledge that its home is once more to be honoured by Royalty. We are most grateful to Her Majesty Queen Elizabeth II for consenting to grace our celebration this evening.' Twenty-three years later those words seem ever more pertinent as the Society once more enlarges its headquarters and embarks on new activities to complement the traditional functions of its Sections. May I therefore draw your attention to the Society Notices in this issue in which the various categories of membership are set out, and urge you to do all you can to promote our Society amongst your colleagues and to encourage those who are not already members to apply for membership. 0141-0768/86/ 040247-02/$02.00/0 o 1986 The Royal Society of Medicine
